CJC-1295, Ipamorelin, and Hexarelin's strongest human data mostly measure GH and IGF-1 levels, sleep, or tolerability in small trials, not strength or lean-mass gains
Your prescriber can confirm this is appropriate for your situation, especially if you take other medications
Baseline labs for safe, informed care We use a focused panel to support safe prescribing and metabolic conversations: CBC & CMP HbA1c TSH hs-CRP (inflammation marker) Ongoing monthly follow-ups If medication is appropriate, youll have structured monthly check-ins to track progress, adjust dosing, and protect lean mass while losing fat
Tirzepatide has shown the largest results so far, with average reductions ranging from 15% to nearly 21% over 72 weeks, depending on dose
Any decision to use GHK-Cu should include honest discussion about evidence gaps